Impact of pharmaceutical care in the improvement of medication adherence and quality of life for COPD patients in Vietnam

Nguyen, Thao Thi; Nguyen, Thi Lien Huong; Pham, Thi Thuy Van; Hua, Susan; Chau, Ngo Quy; Li, Shu Chuen

doi:10.1016/j.rmed.2019.05.006

Cited by 17 publications

(17 citation statements)

References 32 publications

(49 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…While COPD patients aged 75-84 years old (n=115) had more dyspnoea, lower exercise tolerance, poorer activity of daily living, more frequent severe exacerbation, and greater cognitive decline than those aged 65-74 years old (n=101), adherence to inhaled medications did not differ between the groups (good adherence rate =82% for 65-74 years of age and 89% for 75-84 years of age). The percentage of patients with good adherence in Japan is higher than that in 34.7% in South Korea and 37.4% in Vietnam (39,40). The use of ICSs and long-acting muscarinic antagonists (LAMAs) to treat COPD appears to be different from that in other countries.…”

Section: Adherence To Inhaled Medicationsmentioning

confidence: 99%

Narrative review of current COPD status in Japan

Tanabe

Sato

2021

J Thorac Dis

View full text Add to dashboard Cite

Chronic obstructive pulmonary disease (COPD) causes morbidity and mortality worldwide. Due to the improvement in environmental sanitation and medical care, the general life span has increased in the past decades in Japan. However, many older patients with COPD develop a wide range of comorbidities, and the impairments in the activities of daily living result in frailty and increase social and economic burdens.Population-based studies have shown that the prevalence of COPD is approximately 10% among subjects aged ≥40 years, but more than 80% of COPD patients are underdiagnosed. The Ministry of Health, Labour, and Welfare in Japan proposed the National Health Promotion in the 21st century, termed Health Japan 21 (the second term), in 2013 to prevent the onset and progression of noncommunicable diseases (NCDs), including COPD. The government, medical society, and community have been attempting to increase the recognition of COPD and promote smoking cessation. Additionally, Japanese cohorts have revealed distinct clinical features in Japanese patients with COPD, including lower rates of patient-reported exacerbations, less frequent coexisting cardiovascular disease and metabolic syndrome, and lower use of inhaled corticosteroids in Japan compared to the Western countries. Moreover, the poor adherence to inhaled medications is found in approximately 20% of subjects, and rehabilitation is performed in 26% of hospitalized patients with COPD. Therefore, more efforts should be made to improve adherence and access to pulmonary rehabilitation. Overall, Japanese COPD patients share common clinical and social features with COPD patients in other countries. Further international corroboration may help establish better comprehensive management of the disease.

show abstract

Section: Adherence To Inhaled Medicationsmentioning

confidence: 99%

Narrative review of current COPD status in Japan

Tanabe

Sato

2021

J Thorac Dis

View full text Add to dashboard Cite

show abstract

“…It was found that effective interventions were the ones, which had complex blends of numerous strategies. Individualized adherence tools have proved to be effective for adherence (Ostrop & Gill, 2000 Nguyen et al, (2019) reports that quality of life and medication adherence rate improved in patients after implementation of pharmaceutical care programme. The work of Jangi et al, (2018) reports that reminders sent for vaccines proved to be very effective.…”

Section: Discussionmentioning

confidence: 99%

Use of Interventions to Overcome Medication Non-Adherence

Saha

Adhikary

Jha

et al. 2021

International Journal of Asian Business and Information Management

View full text Add to dashboard Cite

Medication non-adherence is a global problem and has existed for centuries. Patients have paid a very high price for their behaviour of non-adherence in the form of impaired cost, prolonged diseases, a burden to family, or even by their lives. In the era of science and technology where there is a solution for every odd problem, the issue of medication non-adherence can also find a remedy. This paper tries to highlight the factors of non-adherence and looks for solutions through various forms of technology. The review of different published literature highlights the findings of researchers and tries to assimilate a solution for addressing the prolonged problem of medication non-adherence.

show abstract

“…Emerging trials suggest that pharmaceutical care has a positive impact on treatment outcomes in COPD patients, especially in the treatment of AECOPD. [103][104][105] In a randomised, controlled, prospective clinical trial, the structured education on COPD and the management of its symptoms which were provided by clinical pharmacists, could significantly improve patients' COPD knowledge, medication adherence, medication beliefs, and hospitalization rates. 106 Another pharmaceutical care programme initiated at the emergency department showed positive clinical benefits due to the reduced number and prevalence of drug-related negative outcomes.…”

Section: Impact Of Pharmacist-led Medication Managementmentioning

confidence: 99%

“…103 In a pre-and post-intervention study over a period of 12 with better adherence was significantly increased from 37.4% to 53.2% through pharmacist-led pharmaceutical care. 104 Furthermore, it was demonstrated that individualized pharmaceutical care also improved inhalation technique, reduced readmissions and elevated health-related quality of life (HRQoL) in patients with COPD. 105,[107][108][109][110][111] In addition, the pharmacists as educators for COPD patients could also reduce medical costs, smoking behavior, and the frequency of lung deterioration.…”

Section: Impact Of Pharmacist-led Medication Managementmentioning

confidence: 99%